Treatment of otitis externa in dogs with beta-(1-adamantyl)-alph

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 3113

Patent

active

043316867

ABSTRACT:
Otitis Externa is treated in dogs by administering to the infected animal a dosage effective to alleviate the symptoms of the infection of a composition of beta-(1-adamantyl)-alpha,alpha-dimethylethylamine or its acid salt and at least one pharmaceutically acceptable carrier wherein the amine (or its salt) is from about 0.01 to about 95% by weight of the composition.

REFERENCES:
patent: 4100170 (1978-07-01), Shetty

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Treatment of otitis externa in dogs with beta-(1-adamantyl)-alph does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of otitis externa in dogs with beta-(1-adamantyl)-alph, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of otitis externa in dogs with beta-(1-adamantyl)-alph will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2076878

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.